CIK 0001821825
- Large accelerated filer
Organon & Co.
Sign in to watch- Ticker
- OGN
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 464838035
- Phone
- +1 551-430-6000
- Business address
- 30 HUDSON STREET, FL 33, JERSEY CITY, NJ, 07302
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 84 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-28 | Falcione Aaron Chief Human Resources Officer | Option exercise | +11,015 | 25,777 | ||
| 2024-02-28 | Falcione Aaron Chief Human Resources Officer | Shares withheld for taxes | −3,960 | $18.04 | $71K | 21,817 |
| 2024-02-28 | Falcione Aaron Chief Human Resources Officer | Option exercise · Restricted Stock Units | −11,015 | 0 | ||
| 2024-02-22 | Weaver Kirke Gen. Counsel & Corp. Secy. | Purchase | +2,720 | $18.36 | $50K | 15,181 |
| 2024-02-09 | DiMarco Kathryn Corporate Controller | Option exercise | +1,871 | 9,388 | ||
| 2024-02-09 | DiMarco Kathryn Corporate Controller | Shares withheld for taxes | −740 | $16.31 | $12K | 8,648 |
| 2024-02-09 | DiMarco Kathryn Corporate Controller | Option exercise · Restricted Stock Units | −1,871 | 0 | ||
| 2023-08-05 | Stahler Rachel A Chief Information Officer | Option exercise | +12,895 | 36,199 | ||
| 2023-08-05 | Stahler Rachel A Chief Information Officer | Shares withheld for taxes | −4,418 | $21.53 | $95K | 31,781 |
| 2023-08-05 | Stahler Rachel A Chief Information Officer | Option exercise · Restricted Stock Units | −12,895 | 0 | ||
| 2023-08-05 | WALSH MATTHEW M Chief Financial Officer | Option exercise | +22,347 | 63,417 | ||
| 2023-08-05 | WALSH MATTHEW M Chief Financial Officer | Shares withheld for taxes | −11,006 | $21.53 | $237K | 52,411 |
| 2023-08-05 | WALSH MATTHEW M Chief Financial Officer | Option exercise · Restricted Stock Units | −22,347 | 0 | ||
| 2023-06-09 | Sharp Shalini Director | Grant or award · Phantom Stock | +10,086 | $19.83 | $200K | 25,594 |
| 2023-06-09 | Whiteford Grace Puma Director | Grant or award · Phantom Stock | +10,086 | $19.83 | $200K | 25,285 |
| 2023-06-09 | Patton Cynthia M Director | Grant or award · Phantom Stock | +10,086 | $19.83 | $200K | 25,285 |
| 2023-06-09 | Ozuah Philip Director | Grant or award · Phantom Stock | +10,086 | $19.83 | $200K | 25,285 |
| 2023-06-09 | McGarry Martha E Director | Grant or award · Phantom Stock | +10,086 | $19.83 | $200K | 25,285 |
| 2023-06-09 | Leone Deborah R Director | Grant or award · Phantom Stock | +10,086 | $19.83 | $200K | 25,285 |
| 2023-06-09 | LAZARUS ROCHELLE B Director | Grant or award · Phantom Stock | +10,086 | $19.83 | $200K | 25,285 |
Page 25 of 33 · 650 trades